In a recent episode of The Glow Up Podcast, Avalon’s Julie Schulz, MD, MPH, Vice President of Product and Michael Dovidio, PharmD, Product Manager, explore how Avalon is transforming healthcare data into action. By integrating lab values, pharmacy claims, and medical data, Avalon’s approach to lab benefit management helps health plans move beyond outdated measures like BMI, to a more complete view of cardiometabolic health that identifies the right patients for high-cost therapies like GLP-1s. This approach supports smarter, more equitable coverage decisions while reducing administrative burden through fewer prior authorizations.

Dr. Schulz and Dr. Dovidio share how Avalon’s access to rich clinical and cost data enables tracking of key population health metrics like A1C levels, medication access, and healthcare disparities with the goal of simplifying complex workflows, closing care gaps, and ensuring the sickest patients receive the treatments they need.

Watch the full episode below: